FoodJun 14, 2017
Hilo Fish Company Frozen Yellowfin tuna cubes, random recall — FDA F-2329-2017
Independent lab testing found positive results for Hepatitis A in tuna products.
Class IFDA: TerminatedHilo Fish Company Inc.
Latest records
Latest recalls — page 1625
The newest recall records with useful source details are listed here.
FoodJun 14, 2017
ISF "USA" High Liner Foods, Lightly Breaded Cod Tail Portions 4 oz recall — FDA F-2271-2017
The firm has decided to recall various products due to undeclared milk.
Class IFDA: TerminatedISF "USA", LLC
FoodJun 14, 2017
Fourth Street Barbeque Pick 5 Chicken & Waffle Sandwich recall — FDA F-2338-2017
Product has the potential to be contaminated with Listeria monocytogenes.
Class IIFDA: TerminatedFourth Street Barbeque, Inc.
FoodJun 14, 2017
Alaska Pasta Company Ravioli Orso recall — FDA F-2351-2017
Undeclared soy lecithin. The firm used Canola oil cooking spray, which contains soy lecithin, in the manufacture of product but soy or soy lecithin is not declared on finished product label.
Class IIFDA: TerminatedAlaska Pasta Company
DrugJun 14, 2017
Zenatane (isotretinoin) Capsules, USP, 40 mg, 30-count recall — FDA D-0886-2017
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugJun 14, 2017
Qualgen Estradiol 15 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12 recall — FDA D-0893-2017
CGMP deviations- Lack of Quality Assurance
Class IIFDA: TerminatedQualgen
DrugJun 14, 2017
Zenatane (isotretinoin) Capsules, USP, 30 mg, 30-count recall — FDA D-0885-2017
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugJun 14, 2017
Spectrum Laboratory Products Levonorgestrel, U.S.P. active pharmaceutical ingredient recall — FDA D-0882-2017
CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current…
Class IIFDA: TerminatedSpectrum Laboratory Products, Inc.
DrugJun 14, 2017
Qualgen Estradiol 6 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12 count recall — FDA D-0896-2017
CGMP deviations- Lack of Quality Assurance
Class IIFDA: TerminatedQualgen
DrugJun 14, 2017
Acyclovir Tablets, USP, 800 mg, 100-count bottle recall — FDA D-0897-2017
Presence of Foreign Substance: human hair melded into tablet.
Class IIIFDA: TerminatedHetero USA Inc.
DrugJun 14, 2017
Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count recall — FDA D-0883-2017
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugJun 14, 2017
Qualgen Estradiol 25 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF, in 1 count, 12 recall — FDA D-0889-2017
CGMP deviations- Lack of Quality Assurance
Class IIFDA: TerminatedQualgen
DrugJun 14, 2017
Qualgen Estradiol 18 mg pellet , 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12 recall — FDA D-0892-2017
CGMP deviations- Lack of Quality Assurance
Class IIFDA: TerminatedQualgen
DrugJun 14, 2017
Qualgen Estradiol 22 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF, in 1 count, 12 recall — FDA D-0890-2017
CGMP deviations- Lack of Quality Assurance
Class IIFDA: TerminatedQualgen
DrugJun 14, 2017
Spectrum Laboratory Products Estradiol recall — FDA D-0881-2017
CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current…
Class IIFDA: TerminatedSpectrum Laboratory Products, Inc.
DrugJun 14, 2017
Qualgen Estradiol 10 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12 recall — FDA D-0895-2017
CGMP deviations- Lack of Quality Assurance
Class IIFDA: TerminatedQualgen
DrugJun 14, 2017
Zenatane (isotretinoin) Capsules, USP, 20 mg, 30-count recall — FDA D-0884-2017
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugJun 14, 2017
Qualgen Estradiol 12.5 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12 recall — FDA D-0894-2017
CGMP deviations- Lack of Quality Assurance
Class IIFDA: TerminatedQualgen
DrugJun 14, 2017
Qualgen Estradiol 20 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count and 12 recall — FDA D-0891-2017
CGMP deviations- Lack of Quality Assurance
Class IIFDA: TerminatedQualgen
Medical DeviceJun 7, 2017
Cell Marque Her2/Neu (c-erbB-2) (CB-1 1) recall — FDA Z-2203-2017
Cell Marque has determined the need to issue a product recall after identifying product intended to be sold outside the U.S. was not properly labeled as "For Export Only" as required by…
Class IIFDA: TerminatedCell Marque Corporation
Medical DeviceJun 7, 2017
Cell Marque Estrogen Receptor (EP1) 7.0 mL Catalog number 249R-28 recall — FDA Z-2200-2017
Cell Marque has determined the need to issue a product recall after identifying product intended to be sold outside the U.S. was not properly labeled as "For Export Only" as required by…
Class IIFDA: TerminatedCell Marque Corporation
Medical DeviceJun 7, 2017
Cell Marque SV40 (MRQ-4) 0.5 ml catalog number 351 M-15 recall — FDA Z-2207-2017
Cell Marque has determined the need to issue a product recall after identifying product intended to be sold outside the U.S. was not properly labeled as "For Export Only" as required by…
Class IIFDA: TerminatedCell Marque Corporation
Medical DeviceJun 7, 2017
Cell Marque Estrogen Receptor (SP1) 7.0 mL Catalog number 249R-18 recall — FDA Z-2201-2017
Cell Marque has determined the need to issue a product recall after identifying product intended to be sold outside the U.S. was not properly labeled as "For Export Only" as required by…
Class IIFDA: TerminatedCell Marque Corporation
Medical DeviceJun 7, 2017
Abbott Vascular Absorb Bioresorbable Vascular Scaffold (BVS) system (Australia) recall — FDA Z-2151-2017
Abbott Vascular is initiating a recall of the Absorb Bioresorbable Vascular Scaffold (BVS) System due to studies showing elevated rates of major adverse events, specifically, myocardial…
Class IFDA: TerminatedAbbott Vascular
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
October 2026245 records · 4 categoriesSeptember 2026363 records · 4 categoriesAugust 2026302 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categories